NewEdge Wealth’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-10,467
| Closed | -$139K | – | 982 |
|
2024
Q4 | $139K | Sell |
10,467
-45,811
| -81% | -$607K | ﹤0.01% | 897 |
|
2024
Q3 | $800K | Sell |
56,278
-16,715
| -23% | -$238K | 0.01% | 517 |
|
2024
Q2 | $945K | Buy |
72,993
+2,365
| +3% | +$30.6K | 0.02% | 429 |
|
2024
Q1 | $937K | Buy |
70,628
+5,708
| +9% | +$75.7K | 0.02% | 439 |
|
2023
Q4 | $926K | Buy |
64,920
+1,290
| +2% | +$18.4K | 0.02% | 413 |
|
2023
Q3 | $984K | Sell |
63,630
-530
| -0.8% | -$8.2K | 0.03% | 361 |
|
2023
Q2 | $1.01M | Sell |
64,160
-341
| -0.5% | -$5.36K | 0.03% | 353 |
|
2023
Q1 | $1.06M | Buy |
64,501
+3,810
| +6% | +$62.8K | 0.04% | 301 |
|
2022
Q4 | $947K | Sell |
60,691
-1,529
| -2% | -$23.9K | 0.04% | 296 |
|
2022
Q3 | $807K | Buy |
62,220
+9,703
| +18% | +$126K | 0.04% | 292 |
|
2022
Q2 | $737K | Buy |
+52,517
| New | +$737K | 0.03% | 326 |
|